Self-renewal as a therapeutic target in human colorectal cancer
…, T Davis, L Cao, R Baiazitov, W Du, N Sydorenko… - Nature medicine, 2014 - nature.com
Tumor recurrence following treatment remains a major clinical challenge. Evidence from
xenograft models and human trials indicates selective enrichment of cancer-initiating cells (CICs…
xenograft models and human trials indicates selective enrichment of cancer-initiating cells (CICs…
[HTML][HTML] Small molecule splicing modifiers with systemic HTT-lowering activity
…, N Risher, S Yeh, Y Cheng, N Sydorenko… - Nature …, 2021 - nature.com
Huntington’s disease (HD) is a hereditary neurodegenerative disorder caused by expansion
of cytosine-adenine-guanine (CAG) trinucleotide repeats in the huntingtin (HTT) gene. …
of cytosine-adenine-guanine (CAG) trinucleotide repeats in the huntingtin (HTT) gene. …
A Formal [3+ 3] Cycloaddition Approach to Natural‐Product Synthesis
…, AV Kurdyumov, N Sydorenko - European journal of …, 2005 - Wiley Online Library
A formal [3 + 3] cycloaddition strategy for constructing complex heterocycles is reviewed here.
This formal cycloaddition involves condensation of α,β‐unsaturated iminium salts with 1,3‐…
This formal cycloaddition involves condensation of α,β‐unsaturated iminium salts with 1,3‐…
BMI-1 targeting interferes with patient-derived tumor-initiating cell survival and tumor growth in prostate cancer
…, E Huselid, M Patrizii, D Jones, L Cao, N Sydorenko… - Clinical cancer …, 2016 - AACR
Purpose: Current prostate cancer management calls for identifying novel and more effective
therapies. Self-renewing tumor-initiating cells (TICs) hold intrinsic therapy resistance and …
therapies. Self-renewing tumor-initiating cells (TICs) hold intrinsic therapy resistance and …
Targeted BMI1 inhibition impairs tumor growth in lung adenocarcinomas with low CEBPα expression
…, O Kocher, P Zhang, YC Moon, N Sydorenko… - Science translational …, 2016 - science.org
Lung cancer is the most common cause of cancer deaths. The expression of the transcription
factor C/EBPα (CCAAT/enhancer binding protein α) is frequently lost in non–small cell lung …
factor C/EBPα (CCAAT/enhancer binding protein α) is frequently lost in non–small cell lung …
Evaluating the mechanism and therapeutic potential of PTC-028, a novel inhibitor of BMI-1 function in ovarian cancer
…, SB Mustafi, P Mukherjee, L Cao, N Sydorenko… - Molecular cancer …, 2018 - AACR
BMI-1, also known as a stem cell factor, is frequently upregulated in several malignancies.
Elevated expression of BMI-1 correlates with poor prognosis and is therefore considered a …
Elevated expression of BMI-1 correlates with poor prognosis and is therefore considered a …
A Lewis acid-catalyzed formal [3+ 3] cycloaddition of α, β-unsaturated aldehydes with 4-hydroxy-2-pyrone, diketones, and vinylogous esters
…, RP Hsung, GC Gullickson, KP Cole, N Sydorenko… - Organic …, 2006 - ACS Publications
… Nadiya Sydorenko … Nadiya Sydorenko - Department of Chemistry, University of
Minnesota, Minneapolis, Minnesota 55455 … Cole, Nadiya Sydorenko, Jacob J. Swidorski …
Minnesota, Minneapolis, Minnesota 55455 … Cole, Nadiya Sydorenko, Jacob J. Swidorski …
A formal [3+ 3] cycloaddition reaction. 5. An enantioselective intramolecular formal aza-[3+ 3] cycloaddition reaction promoted by chiral amine salts
AI Gerasyuto, RP Hsung, N Sydorenko… - The Journal of Organic …, 2005 - ACS Publications
A detailed account on chiral secondary amine salt promoted enantioselective intramolecular
formal aza-[3 + 3] cycloadditions is described here for the first time. The dependence of …
formal aza-[3 + 3] cycloadditions is described here for the first time. The dependence of …
Torquoselective 6π-Electron Electrocyclic Ring Closure of 1-Azatrienes Containing Acyclic Chirality at the C-Terminus
N Sydorenko, RP Hsung, EL Vera - Organic Letters, 2006 - ACS Publications
… Nadiya Sydorenko … Nadiya Sydorenko - Division of Pharmaceutical Sciencies and
Department of Chemistry, Rennebohm Hall, 777 Highland Avenue, University of Wisconsin …
Department of Chemistry, Rennebohm Hall, 777 Highland Avenue, University of Wisconsin …
BMI1 is a therapeutic target in recurrent medulloblastoma
…, H Farooq, S Morrissy, L Cao, N Sydorenko… - Oncogene, 2019 - nature.com
Medulloblastoma (MB) is the most frequent malignant pediatric brain tumor, representing 20%
of newly diagnosed childhood central nervous system malignancies. Although advances …
of newly diagnosed childhood central nervous system malignancies. Although advances …